JACLYN CRAME: Open Payments
NPI 1205472453 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$342 in 12 payments from 5 companies in 2025. Trend: 2023 $95 · 2024 $265 · 2025 $342
Food & beverage: $243Education: $99
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 5 | $104 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| GlaxoSmithKline, LLC. | 4 | $88 |
| Optinose US, Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: DUPIXENT, NUCALA, Xhance.
Industry payments across NV — which companies pay providers there.
